Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11041682 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers
Conditions: Cervical Cancer;   Vulvar Cancer
Intervention: Device: SPECT/CT guided LM/SL

Indicates status has not been verified in more than two years